[CD5-positive cardiac intravascular diffuse large-B cell lymphoma: report of a case]

Zhonghua Bing Li Xue Za Zhi. 2013 Dec;42(12):835-6.
[Article in Chinese]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antigens, CD20 / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • CD5 Antigens / metabolism*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Follow-Up Studies
  • Heart Neoplasms / drug therapy
  • Heart Neoplasms / metabolism
  • Heart Neoplasms / pathology*
  • Heart Neoplasms / surgery
  • Heart Ventricles
  • Humans
  • Interferon Regulatory Factors / metabolism
  • Leukocyte Common Antigens / metabolism
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / surgery
  • Male
  • Middle Aged
  • PAX5 Transcription Factor / metabolism
  • Prednisone / therapeutic use
  • Rituximab
  • Vincristine / therapeutic use

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • CD5 Antigens
  • Interferon Regulatory Factors
  • PAX5 Transcription Factor
  • PAX5 protein, human
  • R-CHOP protocol
  • interferon regulatory factor-4
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Leukocyte Common Antigens
  • Prednisone